MEET AND GREET

SEPTEMBER 2017

Welte T, Pletz M. Pneumonia and the Risk of Cardiovascular Death. Time to Change Our Strategy. Am J Respir Crit Care Med 2017; 196: 541-543 doi:  10.1164/rccm.201707-1421ED.

Skuljec J, Chmielewski M, Happle C, Habener A, Busse M, Abken H, Hansen G. Chimeric Antigen Receptor-Redirected Regulatory T Cells Suppress Experimental Allergic Airway Inflammation, a Model of Asthma. Front Immunol 2017; 8: 1125 doi:  10.3389/fimmu.2017.01125.

Schupp JC, Vukmirovic M, Kaminski N, Prasse A. Transcriptome profiles in sarcoidosis and their potential role in disease prediction. Curr Opin Pulm Med 2017; 23: 487-492 doi:  10.1097/mcp.0000000000000403.

Schumer E, Hoffler K, Kuehn C, Slaughter M, Haverich A, Wiegmann B. In-vitro evaluation of limitations and possibilities for the future use of intracorporeal gas exchangers placed in the upper lobe position. J Artif Organs 2017 10.1007/s10047-017-0987-0.

Salzberger B, Vogelmeier C, Welte T. [Chronic airway infections or colonization by problem pathogens?]. Internist (Berl) 2017 10.1007/s00108-017-0333-x.

Ringshausen FC, Nothdorft S, Langer F, Stoll M. [Endobronchial Dissemination of Metastatic Melanoma without Apparent Primary Tumor]. Pneumologie 2017; 71: 587-589 doi:  10.1055/s-0043-108865.

Rello J, Sole-Lleonart C, Rouby JJ, Chastre J, Blot S, Poulakou G, Luyt CE, Riera J, Palmer LB, Pereira JM, Felton T, Dhanani J, Bassetti M, Welte T, Roberts JA. Use of nebulized antimicrobials for the treatment of respiratory infections in invasively mechanically ventilated adults: a position paper from the European Society of Clinical Microbiology and Infectious Diseases. Clin Microbiol Infect 2017; 23: 629-639 doi:  10.1016/j.cmi.2017.04.011.

Polverino E, Goeminne PC, McDonnell MJ, Aliberti S, Marshall SE, Loebinger MR, Murris M, Canton R, Torres A, Dimakou K, De Soyza A, Hill AT, Haworth CS, Vendrell M, Ringshausen FC, Subotic D, Wilson R, Vilaro J, Stallberg B, Welte T, Rohde G, Blasi F, Elborn S, Almagro M, Timothy A, Ruddy T, Tonia T, Rigau D, Chalmers JD. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J 2017; 50 10.1183/13993003.00629-2017.

Musken M, Klimmek K, Sauer-Heilborn A, Donnert M, Sedlacek L, Suerbaum S, Haussler S. Towards individualized diagnostics of biofilm-associated infections: a case study. NPJ Biofilms Microbiomes 2017; 3: 22 doi:  10.1038/s41522-017-0030-5.

Martin U. Genome stability of programmed stem cell products. Adv Drug Deliv Rev 2017 10.1016/j.addr.2017.09.004.

Jacob A, Morley M, Hawkins F, McCauley KB, Jean JC, Heins H, Na CL, Weaver TE, Vedaie M, Hurley K, Hinds A, Russo SJ, Kook S, Zacharias W, Ochs M, Traber K, Quinton LJ, Crane A, Davis BR, White FV, Wambach J, Whitsett JA, Cole FS, Morrisey EE, Guttentag SH, Beers MF, Kotton DN. Differentiation of Human Pluripotent Stem Cells into Functional Lung Alveolar Epithelial Cells. Cell Stem Cell 2017 10.1016/j.stem.2017.08.014.

Ikari J, Nelson AJ, Obaid J, Giron-Martinez A, Ikari K, Makino F, Iwasawa S, Gunji Y, Farid M, Wang X, Basma H, Demeo D, Feghali-Bostwick C, Holz O, Rabe K, Liu X, Rennard SI. Reduced microRNA-503 expression augments lung fibroblast VEGF production in chronic obstructive pulmonary disease. PLoS One 2017; 12: e0184039 doi:  10.1371/journal.pone.0184039.

Hoeper MM, Vonk-Noordegraaf A. Is there a vanishing pulmonary capillary syndrome? Lancet Respir Med 2017; 5: 676-678 doi:  10.1016/s2213-2600(17)30291-6.

Hoeper MM, Simonneau G, Corris PA, Ghofrani HA, Klinger JR, Langleben D, Naeije R, Jansa P, Rosenkranz S, Scelsi L, Grunig E, Vizza CD, Chang M, Colorado P, Meier C, Busse D, Benza RL. RESPITE: switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors. Eur Respir J 2017; 50 10.1183/13993003.02425-2016.

Herazo-Maya JD, Sun J, Molyneaux PL, Li Q, Villalba JA, Tzouvelekis A, Lynn H, Juan-Guardela BM, Risquez C, Osorio JC, Yan X, Michel G, Aurelien N, Lindell KO, Klesen MJ, Moffatt MF, Cookson WO, Zhang Y, Garcia JGN, Noth I, Prasse A, Bar-Joseph Z, Gibson KF, Zhao H, Herzog EL, Rosas IO, Maher TM, Kaminski N. Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study. Lancet Respir Med 2017 10.1016/s2213-2600(17)30349-1.

Gkika E, Vach W, Adebahr S, Schimeck-Jasch T, Brenner A, Brunner TB, Kaier K, Prasse A, Muller-Quernheim J, Grosu AL, Zissel G, Nestle U. Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)? PLoS One 2017; 12: e0185350 doi:  10.1371/journal.pone.0185350.

Fassunke J, Ihle MA, Lenze D, Lehmann A, Hummel M, Vollbrecht C, Penzel R, Volckmar AL, Stenzinger A, Endris V, Jung A, Lehmann U, Zeugner S, Baretton G, Kreipe H, Schirmacher P, Kirchner T, Dietel M, Buttner R, Merkelbach-Bruse S. EGFR T790M mutation testing of non-small cell lung cancer tissue and blood samples artificially spiked with circulating cell-free tumor DNA: results of a round robin trial. Virchows Arch 2017 10.1007/s00428-017-2226-8.

Bartels S, Persing S, Hasemeier B, Schipper E, Kreipe H, Lehmann U. Molecular Analysis of Circulating Cell-Free DNA from Lung Cancer Patients in Routine Laboratory Practice: A Cross-Platform Comparison of Three Different Molecular Methods for Mutation Detection. J Mol Diagn 2017; 19: 722-732 doi:  10.1016/j.jmoldx.2017.05.008.

Fahndrich S, Biertz F, Karch A, Kleibrink B, Koch A, Teschler H, Welte T, Kauczor HU, Janciauskiene S, Jorres RA, Greulich T, Vogelmeier CF, Bals R. Cardiovascular risk in patients with alpha-1-antitrypsin deficiency. Respir Res 2017; 18: 171 doi:  10.1186/s12931-017-0655-1.

Dittrich AM. [Chronic Pseudomonas aeruginosa airway colonization in cystic fibrosis patients : Prevention concepts]. Internist (Berl) 2017 10.1007/s00108-017-0327-8.

Dettmer S, Shin HO, Vogel-Claussen J, Westphal M, Haverich A, Warnecke G, Welte T, Wacker F, Gottlieb J, Suhling H. CT at onset of chronic lung allograft dysfunction in lung transplant patients predicts development of the restrictive phenotype and survival. Eur J Radiol 2017; 94: 78-84 doi:  10.1016/j.ejrad.2017.06.008.

Conrad A, Janciauskiene S, Kohnlein T, Fuge J, Ivanyi P, Tudorache I, Gottlieb J, Welte T, Fuehner T. Impact of alpha 1-antitrypsin deficiency and prior augmentation therapy on patients' survival after lung transplantation. Eur Respir J 2017; 50 10.1183/13993003.00962-2017.

Behr J, Neuser P, Prasse A, Kreuter M, Rabe K, Schade-Brittinger C, Wagner J, Gunther A. Exploring efficacy and safety of oral Pirfenidone for progressive, non-IPF lung fibrosis (RELIEF) - a randomized, double-blind, placebo-controlled, parallel group, multi-center, phase II trial. BMC Pulm Med 2017; 17: 122 doi:  10.1186/s12890-017-0462-y.

Behr J, Gunther A, Kreuter M, Koschel D, Prasse A, Pfeifer M, Costabel U. [Expert Knowledge and Supporting Advice for the Clinical Use of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis]. Pneumologie 2017; 71: 567-579 doi:  10.1055/s-0043-109856.

Barkhausen J, Kahn T, Krombach GA, Kuhl CK, Lotz J, Maintz D, Ricke J, Schonberg SO, Vogl TJ, Wacker FK. White Paper: Interventional MRI: Current Status and Potential for Development Considering Economic Perspectives, Part 2: Liver and Other Applications in Oncology. Rofo 2017 10.1055/s-0043-112336.

Ackermann M, Gaumann A, Mentzer SJ, Hinrichs JB, Warnecke G, Hoeper MM, Braubach P, Kuehnel M, Maegel L, Jonigk D. Plexiform Vasculopathy in Chronic Thromboembolic Pulmonary Hypertension. Am J Respir Crit Care Med 2017 10.1164/rccm.201703-0591IM.